Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2012
12/04/2012US8323693 External preparation for wounds
12/04/2012US8323692 Controlled release dosage forms
12/04/2012US8323691 Methods and apparatus for determining formulation orientation of multi-layered pharmaceutical dosage forms
12/04/2012US8323690 Solid oral dosage form containing an enhancer
12/04/2012US8323689 Solid oral dosage form containing an enhancer
12/04/2012US8323688 Pharmaceutical compositions comprising hGH for oral delivery
12/04/2012US8323687 Pharmaceutical composition for the prevention and treatment of bone tissue resorption of various etiology
12/04/2012US8323686 Nanostructures suitable for sequestering cholesterol and other molecules
12/04/2012US8323685 Methods of processing compositions containing microparticles
12/04/2012US8323684 Occlusive transdermal therapeutic system with a non-occlusive backing layer
12/04/2012US8323677 Therapeutic foam
12/04/2012US8323675 Soft tissue prosthesis for repairing a defect of an abdominal wall or a pelvic cavity wall
12/04/2012US8323670 Topical compositions of opioid antagonists and methods for treating skin conditions therewith
12/04/2012US8323641 Nanoparticulate compositions having lysozyme as a surface stabilizer
12/04/2012US8323632 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles
12/04/2012US8323623 Pharmaceutical moiré pill
12/04/2012US8323615 Methods of processing multi-phasic dispersions
12/04/2012US8323270 Enhanced method for delivering bevacizumab (avastin) into a brain tumor using an implanted magnetic breather pump
12/04/2012US8323269 Metronomic convection enhanced delivery of intrathecal chemotherapy using an implanted magnetic breather pump (MBP) for leptomeningeal carcinomatosis
12/04/2012US8323267 Infusion device with active and passive check valves
12/04/2012US8323266 Fluid medication delivery device
12/04/2012US8322046 Powder formation by atmospheric spray-freeze drying
12/04/2012CA2708703C Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
12/04/2012CA2696977C Improved pharmaceutical composition containing a pyrrolidone anticonvulsant agent and method for the preparation thereof
12/04/2012CA2675724C Oral extended-release composition
12/04/2012CA2645205C Stable aqueous suspension having palatable taste
12/04/2012CA2644901C System and method for percutaneously administering reduced pressure treatment using a flowable manifold
12/04/2012CA2599340C Method for producing granules
12/04/2012CA2582934C Composition containing omega-3 fatty acids and omega-6 fatty acids
12/04/2012CA2579581C Method for coating powders
12/04/2012CA2567418C Viscous agent for ophthalmic use
12/04/2012CA2551751C Osmotic device containing a venlafaxine salt and a salt having an ion in common
12/04/2012CA2551493C Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
12/04/2012CA2547586C Controlled-release pharmaceutical formulation
12/04/2012CA2538078C Rifalazil formulations
12/04/2012CA2534338C Transdermal formulation comprising an opioid analgesic and an aloe composition
12/04/2012CA2523342C Method for the preparation of molecular complexes
12/04/2012CA2520613C Implantable polymeric device for sustained release of dopamine agonist
12/04/2012CA2515745C Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
12/04/2012CA2485491C Injectable compositions comprising flunixin and florfenicol for treating infection in cattle and swine
12/04/2012CA2474798C Method and composition for treatment of inflammation and aids-associated neurological disorders
12/04/2012CA2462906C Modifications of solid 3-sn-phosphoglycerides
12/04/2012CA2428834C Biodegradable poly(beta-amino esters) and uses thereof
12/04/2012CA2309727C Methods for encapsulating nucleic acids in lipid bilayers
12/04/2012CA2210484C Composition to ameliorate osteolysis and metastasis
12/01/2012CA2778748A1 Particulate preparation and method for producing the same
11/2012
11/29/2012WO2012162629A2 Popcorn shape gold nanoparticle for targeted diagnosis, photothermal treatment and in-situ monitoring therapy response for cancer and multiple drug resistance bacteria
11/29/2012WO2012162567A1 Cb-183,315 compositions and related methods
11/29/2012WO2012162555A2 Heparin nanoclusters
11/29/2012WO2012162492A1 Compressed core comprising organic acids for a pharmaceutical composition
11/29/2012WO2012162287A1 Systems and methods of stimulation and activation of fluids for use with instillation therapy
11/29/2012WO2012162061A1 Delivery of coated hydrophobic active agent particles
11/29/2012WO2012161622A2 Incretin hormone secretion stimulators, method for producing and using same
11/29/2012WO2012161562A1 A process for producing nano-capsules and nano-beadlets containing phytonutrients derived from palm oil
11/29/2012WO2012161520A2 Injectable liquid composition containing docetaxel
11/29/2012WO2012161492A1 Method for preparing microparticles with reduced initial burst and microparticles prepared thereby
11/29/2012WO2012161489A2 Patch containing rivastigmine
11/29/2012WO2012161448A1 Pharmaceutical composition for oral administration in form of suspension comprising revaprazan or its salt
11/29/2012WO2012161240A1 Dry-coated tablet containing tegafur, gimeracil and oteracil potassium
11/29/2012WO2012161196A1 LIPOSOME CONTAINING shRNA MOLECULE FOR THYMIDYLATE SYNTHASE, AND USE FOR SAME
11/29/2012WO2012160485A1 Composition comprising interferon alpha
11/29/2012WO2012160352A1 Pharmaceutical composition of rosuvastatin calcium
11/29/2012WO2012160333A2 Recombinant yeast
11/29/2012WO2012160232A1 Method for obtaining plasma membrane vesicles extracted from plants enriched in membrane transport proteins, and uses thereof
11/29/2012WO2012160223A1 Pharmaceutical composition
11/29/2012WO2012160213A1 Controlled release peptide formulations
11/29/2012WO2012160212A1 Peptide controlled-release formulations
11/29/2012WO2012160203A1 Mucosal delivery of drugs
11/29/2012WO2012160180A2 Pharmaceutical composition for administration to nails
11/29/2012WO2012160179A2 Topical pharmaceutical composition based on semifluorinated alkanes
11/29/2012WO2012160125A1 Compositions for percutaneous administration of physiologically active agents
11/29/2012WO2012160088A1 Bio-compatible nano and microparticles coated with stabilisers for pulmonary application
11/29/2012WO2012160085A1 Bio-compatible nano-polymer particles comprising active ingredients for pulmonary application
11/29/2012WO2012160051A2 Wet granulation methods of cetyl myristate and/or cetyl palmitate
11/29/2012WO2012160050A2 Particle size distribution of cetyl myristate and/or cetyl palmitate
11/29/2012WO2012159964A1 Pharmaceutical composition comprising drotaverine
11/29/2012WO2012159962A1 Pharmaceutical composition comprising ketoprofen
11/29/2012WO2012159960A1 Pharmaceutical composition comprising fexofenadine
11/29/2012WO2012159945A1 Ifn-beta compositions, preparation methods and uses thereof
11/29/2012WO2012159609A1 Powdery mixture for producing tablets containing levetiracetam
11/29/2012WO2012159593A2 A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation
11/29/2012WO2012159552A1 Solid pharmaceutical composition containing benzimidazole derivative
11/29/2012WO2012159511A1 Azilsartan solid dispersion, preparation method and pharmaceutical compositions thereof
11/29/2012WO2012159444A1 Acupoint injection
11/29/2012WO2012159237A1 Quick release-sustained release composition of compound methoxyphenamine
11/29/2012WO2012159173A1 Dose measuring means for a medicine
11/29/2012WO2012159142A1 Oral timed-release formulation
11/29/2012WO2012136224A3 Granulocyte -macrophage colony stimulating factor for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy
11/29/2012WO2012131463A3 Controlled release pharmaceutical dosage forms
11/29/2012WO2012129429A3 Transdermal compositions comprising an active agent layer and an active agent conversion layer
11/29/2012WO2012127105A3 Method for preparation of microcapsules from hemicellulose
11/29/2012WO2012125552A3 Methods of electric field induced delivery of compounds, compositions used in delivery, and system of delivery
11/29/2012WO2012098562A3 Liquid oral compositions of lanthanum salts
11/29/2012WO2012097258A3 Formulations for the prevention and treatment of wolbachia-related disease
11/29/2012WO2012021107A3 A liposomal formulation for ocular drug delivery
11/29/2012WO2011131943A8 Pharmaceutical compositions
11/29/2012WO2011129982A3 Methods for increasing effectiveness of antimicrobial agents in polymeric films
11/29/2012WO2011128627A8 Oral veterinary pharmaceutical and nutraceutical compositions
11/29/2012WO2011104315A3 Immunoglobulin preparation and storage system for an immunoglobulin preparation
11/29/2012US20120303000 Regulator
1 ... 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 ... 2991